Improving the Positive Predictive Value of Non-Invasive Prenatal Screening NIPSReportar como inadecuado

Improving the Positive Predictive Value of Non-Invasive Prenatal Screening NIPS - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

We evaluated performance characteristics of a laboratory-developed, non-invasive prenatal screening NIPS assay for fetal aneuploidies. This assay employs massively parallel shotgun sequencing with full automation. GC sequencing bias correction and statistical smoothing were performed to enhance discrimination of affected and unaffected pregnancies. Maternal plasma samples from pregnancies with known aneuploidy status were used for assay development, verification, and validation. Assay verification studies using 2,085 known samples 1873 unaffected, 69 trisomy 21, 20 trisomy 18, 17 trisomy 13 demonstrated complete discrimination between autosomal trisomy Z scores >8 and unaffected Z scores <4 singleton pregnancies. A validation study using 552 known samples 21 trisomy 21, 10 trisomy 18, 1 trisomy 13 confirmed complete discrimination. Twin pregnancies showed similar results. Follow-up of abnormal results from the first 10,000 clinical samples demonstrated PPVs of 98% 41-42 for trisomy 21, 92% 23-25 for trisomy 18, and 69% 9-13 for trisomy 13. Adjustment for causes of false-positive results identified during clinical testing eg, maternal duplications improved PPVs to 100% for trisomy 21 and 96% for trisomy 18. This NIPS test demonstrates excellent discrimination between trisomic and unaffected pregnancies. The PPVs obtained in initial clinical testing are substantially higher than previously reported NIPS methods.

Autor: Charles M. Strom , Ben Anderson, David Tsao, Ke Zhang, Yan Liu, Kayla Livingston, Christopher Elzinga, Matthew Evans, Quoclinh Ng



Documentos relacionados